0001209191-20-008293.txt : 20200211 0001209191-20-008293.hdr.sgml : 20200211 20200211161638 ACCESSION NUMBER: 0001209191-20-008293 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200207 FILED AS OF DATE: 20200211 DATE AS OF CHANGE: 20200211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jakeman David CENTRAL INDEX KEY: 0001780556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35867 FILM NUMBER: 20596819 MAIL ADDRESS: STREET 1: C/O CHIMERIX, INC., STREET 2: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHIMERIX INC CENTRAL INDEX KEY: 0001117480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330903395 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919.806.1074 MAIL ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-07 0 0001117480 CHIMERIX INC CMRX 0001780556 Jakeman David C/O CHIMERIX, INC. 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 0 1 0 0 Principal Accounting Officer Common Stock 2020-02-07 4 S 0 2290 1.70 D 87876 D The shares were sold in payment of the reporting person's tax liability incurred upon the vesting of shares subject to restricted stock unit awards granted on January 24, 2017, January 25, 2018 and January 23, 2019. /s/ Michael Alrutz, Attorney-in-Fact 2020-02-10